Jason P. Frazier

781 total citations
12 papers, 500 citations indexed

About

Jason P. Frazier is a scholar working on Molecular Biology, Genetics and Genetics. According to data from OpenAlex, Jason P. Frazier has authored 12 papers receiving a total of 500 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Genetics and 2 papers in Genetics. Recurrent topics in Jason P. Frazier's work include Virus-based gene therapy research (2 papers), Cancer Research and Treatments (2 papers) and Ubiquitin and proteasome pathways (2 papers). Jason P. Frazier is often cited by papers focused on Virus-based gene therapy research (2 papers), Cancer Research and Treatments (2 papers) and Ubiquitin and proteasome pathways (2 papers). Jason P. Frazier collaborates with scholars based in United States and Spain. Jason P. Frazier's co-authors include Andrey Loboda, Philippe Soriano, Jeffrey J. Delrow, Philip Corrin, Michele A. Cleary, James Annis, Peter S. Linsley, Aaron N. Chang, B. Nelson Chau and Heather L. Howie and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Genetics and Journal of Clinical Oncology.

In The Last Decade

Jason P. Frazier

11 papers receiving 490 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jason P. Frazier United States	7	397	160	94	50	47	12	500
Laura Rodón United States	6	447 1.1×	212 1.3×	109 1.2×	67 1.3×	46 1.0×	12	552
Azadeh Arabi Iran	11	672 1.7×	193 1.2×	123 1.3×	55 1.1×	51 1.1×	14	795
Madlaina Breuleux Switzerland	8	323 0.8×	154 1.0×	66 0.7×	79 1.6×	58 1.2×	13	486
Xiaomei Sui China	11	330 0.8×	110 0.7×	112 1.2×	41 0.8×	46 1.0×	21	449
Jessica Oddo United States	6	457 1.2×	138 0.9×	87 0.9×	45 0.9×	22 0.5×	10	558
Sang-Hyun Song South Korea	14	512 1.3×	215 1.3×	125 1.3×	97 1.9×	21 0.4×	18	644
Julien H. Dey Switzerland	7	312 0.8×	124 0.8×	104 1.1×	49 1.0×	25 0.5×	7	446
Matti Saarela Finland	6	356 0.9×	112 0.7×	109 1.2×	41 0.8×	82 1.7×	7	497
Cécile Pierre‐Eugène France	11	267 0.7×	82 0.5×	99 1.1×	37 0.7×	49 1.0×	17	427
Tara M. Lichtenberg United States	3	346 0.9×	150 0.9×	193 2.1×	77 1.5×	88 1.9×	7	635

Countries citing papers authored by Jason P. Frazier

Since Specialization

Citations

This map shows the geographic impact of Jason P. Frazier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason P. Frazier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason P. Frazier more than expected).

Fields of papers citing papers by Jason P. Frazier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason P. Frazier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason P. Frazier. The network helps show where Jason P. Frazier may publish in the future.

Co-authorship network of co-authors of Jason P. Frazier

This figure shows the co-authorship network connecting the top 25 collaborators of Jason P. Frazier. A scholar is included among the top collaborators of Jason P. Frazier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason P. Frazier. Jason P. Frazier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Derry, Jonathan M.J., Jason P. Frazier, Marc Grenley, et al.. (2023). Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment. Clinical Cancer Research. 29(18). 3813–3825. 17 indexed citations

Rajasekaran, Karthik, Thomas J. Ow, Cherie‐Ann O. Nathan, et al.. (2023). Multiplexed trackable intratumor microdosing of the investigational STING agonist TAK-676 alone and in combination in the native tumor microenvironment of patients with head and neck cancer: A phase 0 trial.. Journal of Clinical Oncology. 41(16_suppl). 2579–2579. 2 indexed citations

Houlton, Jeffrey, Daniel Clayburgh, Ryan Li, et al.. (2022). 569 A CIVO intratumor microdose Phase 0 Trial of subasumstat (TAK-981) in combination with cetuximab or avelumab reveals Type 1 Interferon induction and immune activation in head and neck cancer patients. Regular and Young Investigator Award Abstracts. A596–A596. 3 indexed citations

Frazier, Jason P., et al.. (2016). Establishment and characterization of a canine soft tissue sarcoma patient‐derived xenograft model. Veterinary and Comparative Oncology. 15(3). 754–763. 2 indexed citations

Dey, Joyoti, William Kerwin, Marc Grenley, et al.. (2016). A Platform for Rapid, Quantitative Assessment of Multiple Drug Combinations Simultaneously in Solid Tumors In Vivo. PLoS ONE. 11(6). e0158617–e0158617. 6 indexed citations

Cosimo, Serena Di, Sriram Sathyanarayanan, Johanna C. Bendell, et al.. (2014). Combination of the mTOR Inhibitor Ridaforolimus and the Anti-IGF1R Monoclonal Antibody Dalotuzumab: Preclinical Characterization and Phase I Clinical Trial. Clinical Cancer Research. 21(1). 49–59. 48 indexed citations

Toyoshima, Masafumi, Heather L. Howie, Ryan Walsh, et al.. (2012). Functional genomics identifies therapeutic targets for MYC-driven cancer. Proceedings of the National Academy of Sciences. 109(24). 9545–9550. 197 indexed citations

Loboda, Andrey, Michael Nebozhyn, Jason P. Frazier, et al.. (2010). A gene expression signature of RAS pathway dependence predicts response to PI3K and RAS pathway inhibitors and expands the population of RAS pathway activated tumors. BMC Medical Genomics. 3(1). 26–26. 107 indexed citations

Klinghoffer, Richard A., Jason P. Frazier, James Annis, et al.. (2009). A Lentivirus-Mediated Genetic Screen Identifies Dihydrofolate Reductase (DHFR) as a Modulator of β-Catenin/GSK3 Signaling. PLoS ONE. 4(9). e6892–e6892. 16 indexed citations

10.

Klinghoffer, Richard A., Brian S. Roberts, James Annis, et al.. (2008). An Optimized Lentivirus-Mediated RNAi Screen Reveals Kinase Modulators of Kinesin-5 Inhibitor Sensitivity. Assay and Drug Development Technologies. 6(1). 105–119. 8 indexed citations

11.

Frazier, Jason P., et al.. (2006). Cisco Network Admission Control, Volume I: NAC Framework Architecture and Design (Networking Technology).

12.

Delrow, Jeffrey J., et al.. (2004). Identification and validation of PDGF transcriptional targets by microarray-coupled gene-trap mutagenesis. Nature Genetics. 36(3). 304–312. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact